yttrium radioisotopes has been researched along with Synovioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harada, Y; Higashi, T; Katagiri, T; Nagayama, S; Nakamura, Y; Sudo, H; Sugyo, A; Tsuji, AB | 1 |
| Alberti, L; Baconnier, S; Badel, JN; Berge-Montamat, S; Blay, JY; Cassier, PA; Chabaud, S; Clapisson, G; Cropet, C; Desuzinges, C; Garin, G; Gilles-Afchain, L; Giraudet, AL; Halty, A; Italiano, A; Iwao-Fukukawa, C; Katagiri, T; Kryza, D; Mori, M; Nakamura, Y; Pérol, D; Sarrut, D; Tsunoda, T | 1 |
1 trial(s) available for yttrium radioisotopes and Synovioma
| Article | Year |
|---|---|
A first-in-human study investigating biodistribution, safety and recommended dose of a new radiolabeled MAb targeting FZD10 in metastatic synovial sarcoma patients.
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Agents, Immunological; Dose-Response Relationship, Drug; Female; Frizzled Receptors; Humans; Male; Middle Aged; Radioimmunotherapy; Sarcoma, Synovial; Tissue Distribution; Young Adult; Yttrium Radioisotopes | 2018 |
1 other study(ies) available for yttrium radioisotopes and Synovioma
| Article | Year |
|---|---|
FZD10-targeted α-radioimmunotherapy with
Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Frizzled Receptors; Humans; Mice; Radioimmunotherapy; Radiotherapy Dosage; Remission Induction; Sarcoma, Synovial; Tissue Distribution; Tumor Burden; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2022 |